ArticlePharmacology research & perspectives2022

Real-world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience.

Josephine A Adattini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.